Larry B. Goldstein, MD


Professor of Neurology
Director, Duke Stroke Center
Department / Division:
Neurology / Stroke and Vascular Neurology
Address:
DUMC 3651
Durham, NC 27710
Appointment Telephone:
919-668-7600
Office Telephone:
919-684-3801
Fax:
919-684-6514
Training:
  • MD, Mount Sinai School of Medicine of New York University, 1981
Residency:
  • Neurology, Mount Sinai Medical Center (New York), 1981-1985
Fellowship:
  • Cerebrovascular Research, Duke University Medical Center, 1985-1987
Other Training:
  • Board Certifications, Neurology and Vascular Neurology
Clinical Interests:
Stroke, cerebrovascular disease, TIAs
Representative Publications:
  • Martin, KD; Naert, L; Goldstein, LB; Kasl, S; Molinaro, AM; Lichtman, JH. Comparing the use of diagnostic imaging and receipt of carotid endarterectomy in elderly black and white stroke patients. Journal of Stroke and Cerebrovascular Diseases. 2012;21:600-606.  Abstract
  • Zhang, L; Harrison, JK; Goldstein, LB. Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. Journal of Stroke and Cerebrovascular Diseases. 2012;21:577-582.  Abstract
  • Albers, GW; Goldstein, LB; Hess, DC; Wechsler, LR; Furie, KL; Gorelick, PB; Hurn, P; Liebeskind, DS; Nogueira, RG; Saver, JL; STAIR VII Consortium. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011;42:2645-2650.  Abstract
  • Brainin, M; Norrving, B; Sunnerhagen, KS; Goldstein, LB; Cramer, SC; Donnan, GA; Duncan, PW; Francisco, G; Good, D; Graham, G; Kissela, BM; Olver, J; Ward, A; Wissel, J; Zorowitz, R; International PSS Disability Study Group. Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. International Journal of Stroke. 2011;6:42-46.  Abstract
  • Bushnell, CD; Olson, DM; Zhao, X; Pan, W; Zimmer, LO; Goldstein, LB; Alberts, MJ; Fagan, SC; Fonarow, GC; Johnston, SC; Kidwell, C; Labresh, KA; Ovbiagele, B; Schwamm, L; Peterson, ED; AVAIL Investigators. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77:1182-1190.  Abstract
  • Callahan, A; Amarenco, P; Goldstein, LB; Sillesen, H; Messig, M; Samsa, GP; Altafullah, I; Ledbetter, LY; MacLeod, MJ; Scott, R; Hennerici, M; Zivin, JA; Welch, KM; SPARCL Investigators. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Archives of Neurology. 2011;68:1245-1251.  Abstract
  • Cohen, DJ; Stolker, JM; Wang, K; Magnuson, EA; Clark, WM; Demaerschalk, BM; Sam, AD; Elmore, JR; Weaver, FA; Aronow, HD; Goldstein, LB; Roubin, GS; Howard, G; Brott, TG; CREST Investigators. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). Journal of the American College of Cardiology. 2011;58:1557-1565.  Abstract
  • El Husseini, N; Shea, KJ; Goldstein, LB. Concerns for the reliability and validity of the National Stroke Project Stroke Severity Scale. Cerebrovascular Diseases. 2011;32:426-430.  Abstract
  • Goldstein, LB. Left atrial enlargement: a cause of stroke?. CMAJ. 2011;183:1129-1130.  Abstract
  • Goldstein, LB. Novel platelet antiaggregants and the changing landscape of stroke prevention. Lancet Neurology. 2011;10:678-680.  Abstract
  • Goldstein, LB. Statins after intracerebral hemorrhage: to treat or not to treat. Archives of Neurology. 2011;68:565-566.  Abstract
  • Goldstein, LB. Stroke: Organizing the disorganized: improving TIA patient care. Nature Reviews. Neurology. 2011;7:190-192.  Abstract
  • Goldstein, LB; Bushnell, CD; Adams, RJ; Appel, LJ; Braun, LT; Chaturvedi, S; Creager, MA; Culebras, A; Eckel, RH; Hart, RG; Hinchey, JA; Howard, VJ; Jauch, EC; Levine, SR; Meschia, JF; Moore, WS; Nixon, JV; Pearson, TA; American Heart Association Stroke Council, ; Council on Cardiovascular Nursing, ; Council on Epidemiology and Prevention, ; Council for High Blood Pressure Research,, ; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.  Abstract
  • Goldstein, LB; El Husseini, N. [Neurology and cardiology: points of contact]. Revista Espanola de Cardiologia. 2011;64:319-327.  Abstract
  • Goldstein, LB; Whitsel, LP; Meltzer, N; Schoeberl, M; Birnbaum, J; Nelson, S; Gardner, TJ; Yancy, CW; Gibbons, RJ; Sacco, RL; Hiratzka, L; American Heart Association (AHA) Advocacy Coordinating Committee, ; Council on Cardiovascular Nursing, AHA, ; Council on the Kidney in Cardiovascular Disease, AHA, ; Council on Cardiovascular Radiology and Intervention, AHA, ; Council on Cardiovascular Surgery and Anesthesia, AHA, ; Council on Clinical Cardiology, AHA, ; Council on Cardiovascular Disease in the Young, AHA, ; Council on Cardiopulmonary, Critical Care, Perioperative, and Resuscitation, AHA, ; Council on Peripheral Vascular Disease, AHA, ; Council on Arteriosclerosis, Thrombosis and Vascular Biology, AHA, ; Council on Epidemiology and Prevention, AHA, ; Council on Nutrition, Physical Activ. . . American Heart Association and nonprofit advocacy: past, present, and future. A policy recommendation from the American Heart Association. Circulation. 2011;123:816-832.  Abstract
  • Hegland, D; Piccini, JP; Goldstein, LB; Daubert, JP. Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study?. Journal of Cardiovascular Electrophysiology. 2011;22:969-972.  Abstract
  • Lichtman, JH; Jones, SB; Leifheit-Limson, EC; Wang, Y; Goldstein, LB. 30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. Stroke. 2011;42:3387-3391.  Abstract
  • Lichtman, JH; Jones, SB; Wang, Y; Watanabe, E; Leifheit-Limson, E; Goldstein, LB. Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. Neurology. 2011;76:1976-1982.  Abstract
  • Lichtman, JH; Naert, L; Allen, NB; Watanabe, E; Jones, SB; Barry, LC; Bravata, DM; Goldstein, LB. Use of antithrombotic medications among elderly ischemic stroke patients. Circulation: Cardiovascular Quality and Outcomes. 2011;4:30-38.  Abstract
  • Plant, SR; Samsa, GP; Shah, SH; Goldstein, LB. Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. Cerebrovascular Diseases. 2011;31:117-122.  Abstract
  • Rodriguez, D; Cox, M; Zimmer, LO; Olson, DM; Goldstein, LB; Drew, L; Peterson, ED; Bushnell, CD; AVAIL Investigators. Similar secondary stroke prevention and medication persistence rates among rural and urban patients. Journal of Rural Health. 2011;27:401-408.  Abstract
  • Silver, FL; Mackey, A; Clark, WM; Brooks, W; Timaran, CH; Chiu, D; Goldstein, LB; Meschia, JF; Ferguson, RD; Moore, WS; Howard, G; Brott, TG; CREST Investigators. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011;42:675-680.  Abstract
  • Allen, NB; Holford, TR; Bracken, MB; Goldstein, LB; Howard, G; Wang, Y; Lichtman, JH. Geographic variation in one-year recurrent ischemic stroke rates for elderly Medicare beneficiaries in the USA. Neuroepidemiology. 2010;34:123-129.  Abstract
  • Allen, NB; Holford, TR; Bracken, MB; Goldstein, LB; Howard, G; Wang, Y; Lichtman, JH. Trends in one-year recurrent ischemic stroke among the elderly in the USA: 1994-2002. Cerebrovascular Diseases. 2010;30:525-532.  Abstract
  • Amarenco, P; Goldstein, LB; Sillesen, H; Benavente, O; Zweifler, RM; Callahan, A; Hennerici, MG; Zivin, JA; Welch, KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2010;41:426-430.  Abstract
  • Goldstein, LB. Physical activity and the risk of stroke. Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders. 2010;10:1263-1265.  Abstract
  • Goldstein, LB. Statewide hospital-based stroke services in North Carolina: changes over 10 years. Stroke. 2010;41:778-783.  Abstract
  • Goldstein, LB; Rothwell, PM. Advances in prevention and health services delivery 2009. Stroke. 2010;41:e71-e73.  Abstract
  • Hachinski, V; Donnan, GA; Gorelick, PB; Hacke, W; Cramer, SC; Kaste, M; Fisher, M; Brainin, M; Buchan, AM; Lo, EH; Skolnick, BE; Furie, KL; Hankey, GJ; Kivipelto, M; Morris, J; Rothwell, PM; Sacco, RL; Smith, SC; Wang, Y; Bryer, A; Ford, GA; Iadecola, C; Martins, SC; Saver, J; Skvortsova, V; Bayley, M; Bednar, MM; Duncan, P; Enney, L; Finklestein, S; Jones, TA; Kalra, L; Kleim, J; Nitkin, R; Teasell, R; Weiller, C; Desai, B; Goldberg, MP; Heiss, WD; Saarelma, O; Schwamm, LH; Shinohara, Y; Trivedi, B; Wahlgren, N; Wong, LK; Hakim, A; Norrving, B; Prudhomme, S; Bornstein, NM; Davis, SM; Goldstein, LB; Leys, D; Tuomilehto, J; Stroke Synergium. Stroke: working toward a prioritized world agenda. Cerebrovascular Diseases. 2010;30:127-147.  Abstract
  • Kernan, WN; Launer, LJ; Goldstein, LB. What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification. Stroke. 2010;41:S35-S38.  Abstract
  • Krishnan, A; Lopes, RD; Alexander, JH; Becker, RC; Goldstein, LB. Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician. Journal of Thrombosis and Thrombolysis. 2010;29:368-377.  Abstract
  • Lichtman, JH; Jones, SB; Wang, Y; Watanabe, E; Allen, NB; Fayad, P; Goldstein, LB. Postendarterectomy mortality in octogenarians and nonagenarians in the USA from 1993 to 1999. Cerebrovascular Diseases. 2010;29:154-161.  Abstract
  • Lichtman, JH; Leifheit-Limson, EC; Jones, SB; Watanabe, E; Bernheim, SM; Phipps, MS; Bhat, KR; Savage, SV; Goldstein, LB. Predictors of hospital readmission after stroke: a systematic review. Stroke. 2010;41:2525-2533.  Abstract
  • Marquine, MJ; Attix, DK; Goldstein, LB; Samsa, GP; Payne, ME; Chelune, GJ; Steffens, DC. Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke. 2010;41:1946-1950.  Abstract
  • Schwamm, L; Fayad, P; Acker, JE; Duncan, P; Fonarow, GC; Girgus, M; Goldstein, LB; Gregory, T; Kelly-Hayes, M; Sacco, RL; Saver, JL; Segrest, W; Solis, P; Yancy, CW. Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association. Stroke. 2010;41:1051-1065.  Abstract
  • Xu, H; Stamova, B; Jickling, G; Tian, Y; Zhan, X; Ander, BP; Liu, D; Turner, R; Rosand, J; Goldstein, LB; Furie, KL; Verro, P; Johnston, SC; Sharp, FR; Decarli, CS. Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke. 2010;41:2744-2749.  Abstract
  • Adkins, DL; Schallert, T; Goldstein, LB. Poststroke treatment: lost in translation. Stroke. 2009;40:8-9.  Abstract
  • Allen, NB; Myers, D; Watanabe, E; Dostal, J; Sama, D; Goldstein, LB; Lichtman, JH. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?. Cerebrovascular Diseases. 2009;27:254-258.  Abstract
  • Amarenco, P; Benavente, O; Goldstein, LB; Callahan, A; Sillesen, H; Hennerici, MG; Gilbert, S; Rudolph, AE; Simunovic, L; Zivin, JA; Welch, KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009;40:1405-1409.  Abstract
  • Amarenco, P; Goldstein, LB; Callahan, A; Sillesen, H; Hennerici, MG; O'Neill, BJ; Rudolph, AE; Simunovic, L; Zivin, JA; Welch, KM; SPARCL Investigators. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009;204:515-520.  Abstract
  • Amarenco, P; Goldstein, LB; Messig, M; O'Neill, BJ; Callahan, A; Sillesen, H; Hennerici, MG; Zivin, JA; Welch, KM; SPARCL Investigators. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009;40:2486-2492.  Abstract
  • Bushnell, C; Zimmer, L; Schwamm, L; Goldstein, LB; Clapp-Channing, N; Harding, T; Drew, L; Zhao, X; Peterson, E; AVAIL registry. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. American Heart Journal. 2009;157:428-435.e2.  Abstract
  • Chaturvedi, S; Zivin, J; Breazna, A; Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, M; Sillesen, H; Rudolph, A; Welch, MA; SPARCL Investigators. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009;72:688-694.  Abstract
  • Frendl, DM; Strauss, DG; Underhill, BK; Goldstein, LB. Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke. 2009;40:754-756.  Abstract
  • Galbreath, AD; Goldstein, LB. Dysnomia, ataxia, choreoathetosis, sensory impairment, and gait imbalance after lentiform nucleus stroke. Journal of Stroke and Cerebrovascular Diseases. 2009;18:494-496.  Abstract
  • Gibbons, RJ; Gardner, TJ; Anderson, JL; Goldstein, LB; Meltzer, N; Weintraub, WS; Yancy, CW; American Heart Association Advocacy Coordinating Committee. The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation. 2009;119:2955-2962.  Abstract
  • Goldstein, LB. Amphetamine trials and tribulations. Stroke. 2009;40:S133-S135.  Abstract
  • Goldstein, LB. Clopidogrel plus aspirin in atrial fibrillation. New England Journal of Medicine. 2009;361:1313.  Abstract
  • Goldstein, LB. Eating yourself to a stroke?. Annals of Neurology. 2009;66:129-131.  Abstract
  • Goldstein, LB. JUPITER and the world of stroke medicine. Lancet Neurology. 2009;8:129-131.  Abstract
  • Goldstein, LB. New data about stenting versus endarterectomy for symptomatic carotid artery stenosis. Current Treatment Options in Cardiovascular Medicine. 2009;11:232-240.  Abstract
  • Goldstein, LB. Statins and ischemic stroke severity: cytoprotection. Current Atherosclerosis Reports. 2009;11:296-300.  Abstract
  • Goldstein, LB. Stroke recovery and rehabilitation. Handbook of Clinical Neurology. 2009;94:1327-1337.  Abstract
  • Goldstein, LB. The 2009 Feinberg lecture: the continuum of stroke research and policy. Stroke. 2009;40:3879-3882.  Abstract
  • Goldstein, LB. The cart and the horse: the advancing technology of carotid artery stenting. Circulation: Cardiovascular Interventions. 2009;2:153-155.  Abstract
  • Goldstein, LB. The complex relationship between cholesterol and brain hemorrhage. Circulation. 2009;119:2131-2133.  Abstract
  • Goldstein, LB; Amarenco, P; Zivin, J; Messig, M; Altafullah, I; Callahan, A; Hennerici, M; MacLeod, MJ; Sillesen, H; Zweifler, R; Michael, K; Welch, A; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009;40:3526-3531.  Abstract
  • Goldstein, LB; Rothwell, PM. Advances in primary prevention and health services delivery. Stroke. 2009;40:e295-e297.  Abstract
  • Goldstein, LB; Silberberg, M; McMiller, Y; Yaggy, SD. Stroke-related knowledge among uninsured Latino immigrants in Durham County, North Carolina. Journal of Stroke and Cerebrovascular Diseases. 2009;18:229-231.  Abstract
  • Goldstein, LB; Suarez, JI. The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009;73:2058-2059.  Abstract
  • Lichtman, JH; Allen, NB; Wang, Y; Watanabe, E; Jones, SB; Goldstein, LB. Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke. 2009;40:3574-3579.  Abstract
  • Lichtman, JH; Jones, SB; Watanabe, E; Allen, NB; Wang, Y; Howard, VJ; Goldstein, LB. Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. Stroke. 2009;40:2116-2122.  Abstract
  • Lichtman, JH; Watanabe, E; Allen, NB; Jones, SB; Dostal, J; Goldstein, LB. Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke. 2009;40:3845-3850.  Abstract
  • Smith Hammond, CA; Goldstein, LB; Horner, RD; Ying, J; Gray, L; Gonzalez-Rothi, L; Bolser, DC. Predicting aspiration in patients with ischemic stroke: comparison of clinical signs and aerodynamic measures of voluntary cough. Chest. 2009;135:769-777.  Abstract
  • Watanabe, E; Allen, NB; Dostal, J; Sama, D; Claus, EB; Goldstein, LB; Lichtman, JH. Diagnostic evaluation for patients with ischemic stroke: are there sex differences?. Cerebrovascular Diseases. 2009;27:450-455.  Abstract
  • Abou-Donia, MB; Goldstein, LB; Bullman, S; Tu, T; Khan, WA; Dechkovskaia, AM; Abdel-Rahman, AA. Imidacloprid induces neurobehavioral deficits and increases expression of glial fibrillary acidic protein in the motor cortex and hippocampus in offspring rats following in utero exposure. Journal of Toxicology and Environmental Health Part A. 2008;71:119-130.  Abstract
  • Adams, RJ; Albers, G; Alberts, MJ; Benavente, O; Furie, K; Goldstein, LB; Gorelick, P; Halperin, J; Harbaugh, R; Johnston, SC; Katzan, I; Kelly-Hayes, M; Kenton, EJ; Marks, M; Sacco, RL; Schwamm, LH; American Heart Association, ; American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647-1652.  Abstract
  • Bushnell, CD; Lee, J; Duncan, PW; Newby, LK; Goldstein, LB. Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008;39:2138-2140.  Abstract
  • Gibbons, RJ; Jones, DW; Gardner, TJ; Goldstein, LB; Moller, JH; Yancy, CW; American Heart Association. The American Heart Association's 2008 Statement of Principles for Healthcare Reform. Circulation. 2008;118:2209-2218.  Abstract
  • Goldstein, LB. 10 questions about statins and stroke. The Neurologist. 2008;14:262-264.  Abstract
  • Goldstein, LB. Anticoagulation for atrial fibrillation in the elderly: part 1. Current Atherosclerosis Reports. 2008;10:284-285.  Abstract
  • Goldstein, LB. Anticoagulation for atrial fibrillation in the elderly: part 2. Current Atherosclerosis Reports. 2008;10:285-286.  Abstract
  • Goldstein, LB. How much can be gained by more systematic prevention of stroke?. International Journal of Stroke. 2008;3:266-271.  Abstract
  • Goldstein, LB. Minocycline treatment in acute stroke. Current Atherosclerosis Reports. 2008;10:286-287.  Abstract
  • Goldstein, LB. Primary central nervous system vasculitis: is biopsy appropriate?. Annals of Neurology. 2008;64:228.  Abstract
  • Goldstein, LB. Reducing death and disability from stroke: the role of governmental advocacy. Stroke. 2008;39:2898-2901.  Abstract
  • Goldstein, LB. Should angioplasty and stenting be performed before CAGB in patients with asymptomatic carotid stenosis?. Nature Reviews: Neurology. 2008;4:250-251.  Abstract
  • Goldstein, LB; Amarenco, P; Lamonte, M; Gilbert, S; Messig, M; Callahan, A; Hennerici, M; Sillesen, H; Welch, KM; SPARCL Investigators. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008;39:2444-2448.  Abstract
  • Goldstein, LB; Amarenco, P; Szarek, M; Callahan, A; Hennerici, M; Sillesen, H; Zivin, JA; Welch, KM; SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008;70:2364-2370.  Abstract
  • Goldstein, LB; Rothwell, PM. Advances in prevention and health services delivery 2007. Stroke. 2008;39:258-260.  Abstract
  • Sillesen, H; Amarenco, P; Hennerici, MG; Callahan, A; Goldstein, LB; Zivin, J; Messig, M; Welch, KM; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39:3297-3302.  Abstract
  • Amarenco, P; Goldstein, LB; Szarek, M; Sillesen, H; Rudolph, AE; Callahan, A; Hennerici, M; Simunovic, L; Zivin, JA; Welch, KM; SPARCL Investigators. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007;38:3198-3204.  Abstract
  • Fletcher, GF; Bufalino, V; Costa, F; Goldstein, LB; Jones, D; Smaha, L; Smith, SC; Stone, N. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. American Journal of Cardiology. 2007;99:1E-35E.  Abstract
  • Goldstein, LB. Acute ischemic stroke treatment in 2007. Circulation. 2007;116:1504-1514.  Abstract
  • Goldstein, LB. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE trial. Current Atherosclerosis Reports. 2007;9:259-260.  Abstract
  • Goldstein, LB. Low LDL cholesterol, statins, and brain hemorrhage: should we worry?. Neurology. 2007;68:719-720.  Abstract
  • Goldstein, LB. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the DEFUSE study. Current Atherosclerosis Reports. 2007;9:258-259.  Abstract
  • Goldstein, LB. Regulatory device approval for stroke: fair and balanced?. Stroke. 2007;38:1737-1738.  Abstract
  • Goldstein, LB. Statins for stroke prevention. Current Atherosclerosis Reports. 2007;9:305-311.  Abstract
  • Goldstein, LB. Stroke code chest radiographs are not useful. Cerebrovascular Diseases. 2007;24:460-462.  Abstract
  • Goldstein, LB; Rothwell, PM. Primary prevention and health services delivery. Stroke. 2007;38:222-224.  Abstract
  • Abou-Donia, MB; Khan, WA; Dechkovskaia, AM; Goldstein, LB; Bullman, SL; Abdel-Rahman, A. In utero exposure to nicotine and chlorpyrifos alone, and in combination produces persistent sensorimotor deficits and Purkinje neuron loss in the cerebellum of adult offspring rats. Archives of Toxicology. 2006;80:620-631.  Abstract
  • Amarenco, P; Bogousslavsky, J; Callahan, A; Goldstein, LB; Hennerici, M; Rudolph, AE; Sillesen, H; Simunovic, L; Szarek, M; Welch, KM; Zivin, JA; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine. 2006;355:549-559.  Abstract
  • Bushnell, CD; Griffin, J; Newby, LK; Goldstein, LB; Mahaffey, KW; Graffagnino, CA; Harrington, RA; White, HD; Simes, RJ; Califf, RM; Topol, EJ; Easton, JD. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke. 2006;37:1427-1431.  Abstract
  • Bushnell, CD; Hurn, P; Colton, C; Miller, VM; del Zoppo, G; Elkind, MS; Stern, B; Herrington, D; Ford-Lynch, G; Gorelick, P; James, A; Brown, CM; Choi, E; Bray, P; Newby, LK; Goldstein, LB; Simpkins, J. Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke. 2006;37:2387-2399.  Abstract
  • Goldstein, LB. Improving the clinical diagnosis of stroke. Stroke. 2006;37:754-755.  Abstract
  • Goldstein, LB. Is there a causal relationship between the amount of alcohol consumption and stroke risk?. Stroke. 2006;37:1-2.  Abstract
  • Goldstein, LB. Neurotransmitters and motor activity: effects on functional recovery after brain injury. NeuroRx. 2006;3:451-457.  Abstract
  • Goldstein, LB. Primum non nocere: antithombotics after intracerebral hemorrhage?. Neurology. 2006;66:162-163.  Abstract
  • Goldstein, LB; Adams, R; Alberts, MJ; Appel, LJ; Brass, LM; Bushnell, CD; Culebras, A; DeGraba, TJ; Gorelick, PB; Guyton, JR; Hart, RG; Howard, G; Kelly-Hayes, M; Nixon, JV; Sacco, RL; American Heart Association, ; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113:e873-e923.  Abstract
  • Goldstein, LB; Adams, R; Alberts, MJ; Appel, LJ; Brass, LM; Bushnell, CD; Culebras, A; Degraba, TJ; Gorelick, PB; Guyton, JR; Hart, RG; Howard, G; Kelly-Hayes, M; Nixon, JV; Sacco, RL; American Heart Association/American Stroke Association Stroke Council, ; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group, ; Cardiovascular Nursing Council, ; Clinical Cardiology Council, ; Nutrition, Physical Activity, and Metabolism Council, ; Quality of Care and Outcomes Research Interdisciplinary Working Group, ; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633.  Abstract
  • Goldstein, LB; Hankey, GJ. Advances in primary stroke prevention. Stroke. 2006;37:317-319.  Abstract
  • Goldstein, LB; Saver, JL. Thrombolysis in stroke: a medicolegal quagmire. Stroke. 2006;37:2663.  Abstract
  • Irwin, RS; Baumann, MH; Bolser, DC; Boulet, LP; Braman, SS; Brightling, CE; Brown, KK; Canning, BJ; Chang, AB; Dicpinigaitis, PV; Eccles, R; Glomb, WB; Goldstein, LB; Graham, LM; Hargreave, FE; Kvale, PA; Lewis, SZ; McCool, FD; McCrory, DC; Prakash, UB; Pratter, MR; Rosen, MJ; Schulman, E; Shannon, JJ; Smith Hammond, C; Tarlo, SM; American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:1S-23S.  Abstract
  • Kaplan, KL; Goldstein, LB. What does cerebral platelet activation mean in the setting of carotid stenosis?. Neurology. 2006;66:792-793.  Abstract
  • Sacco, RL; Adams, R; Albers, G; Alberts, MJ; Benavente, O; Furie, K; Goldstein, LB; Gorelick, P; Halperin, J; Harbaugh, R; Johnston, SC; Katzan, I; Kelly-Hayes, M; Kenton, EJ; Marks, M; Schwamm, LH; Tomsick, T; American Heart Association, ; American Stroke Association Council on Stroke, ; Council on Cardiovascular Radiology and Intervention, ; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617.  Abstract
  • Sacco, RL; Adams, R; Albers, G; Alberts, MJ; Benavente, O; Furie, K; Goldstein, LB; Gorelick, P; Halperin, J; Harbaugh, R; Johnston, SC; Katzan, I; Kelly-Hayes, M; Kenton, EJ; Marks, M; Schwamm, LH; Tomsick, T; American Heart Association/American Stroke Association Council on Stroke, ; Council on Cardiovascular Radiology and Intervention, ; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409-e449.  Abstract
  • Saver, JL; Goldstein, LB. The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke. 2006;37:753.  Abstract
  • Smith Hammond, CA; Goldstein, LB. Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:154S-168S.  Abstract
  • Adams, H; Adams, R; Del Zoppo, G; Goldstein, LB; Stroke Council of the American Heart Association, ; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36:916-923.  Abstract
  • Bushnell, CD; Goldstein, LB. Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients. Journal of Stroke and Cerebrovascular Diseases. 2005;14:101-106.  Abstract
  • Camilo, O; Goldstein, LB. Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey. Neurology. 2005;64:762-763.  Abstract
  • Camilo, O; Goldstein, LB. Non-atherosclerotic vascular disease in the young. Journal of Thrombosis and Thrombolysis. 2005;20:93-103.  Abstract
  • Goldstein, LB; Amarenco, P. Prevention and health services delivery. Stroke. 2005;36:222-224.  Abstract
  • Goldstein, LB; Simel, DL. Is this patient having a stroke?. JAMA: Journal of the American Medical Association. 2005;293:2391-2402.  Abstract
  • Schwamm, LH; Pancioli, A; Acker, JE; Goldstein, LB; Zorowitz, RD; Shephard, TJ; Moyer, P; Gorman, M; Johnston, SC; Duncan, PW; Gorelick, P; Frank, J; Stranne, SK; Smith, R; Federspiel, W; Horton, KB; Magnis, E; Adams, RJ; American Stroke Association's Task Force on the Development of Stroke Systems. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005;111:1078-1091.  Abstract
  • Schwamm, LH; Pancioli, A; Acker, JE; Goldstein, LB; Zorowitz, RD; Shephard, TJ; Moyer, P; Gorman, M; Johnston, SC; Duncan, PW; Gorelick, P; Frank, J; Stranne, SK; Smith, R; Federspiel, W; Horton, KB; Magnis, E; Adams, RJ; American Stroke Association's Task Force on the Development of Stroke Systems. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke. 2005;36:690-703.  Abstract
  • Abdel-Rahman, A; Dechkovskaia, AM; Goldstein, LB; Bullman, SH; Khan, W; El-Masry, EM; Abou-Donia, MB. Neurological deficits induced by malathion, DEET, and permethrin, alone or in combination in adult rats. Journal of Toxicology and Environmental Health Part A. 2004;67:331-356.  Abstract
  • Abou-Donia, MB; Dechkovskaia, AM; Goldstein, LB; Abdel-Rahman, A; Bullman, SL; Khan, WA. Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. Pharmacology, Biochemistry and Behavior. 2004;77:253-262.  Abstract
  • Anderson, DC; Goldstein, LB. Aspirin: it's hard to beat. Neurology. 2004;62:1036-1037.  Abstract
  • Bonow, RO; Zipes, DP; Anderson, JL; Cheitlin, MD; Goldstein, LB; Grant, AO; Faxon, D; Lima, JA; Robertson, RM. Task force 5: Expert testimony and opinions. Journal of the American College of Cardiology. 2004;44:1747-1749.  Abstract
  • Bushnell, CD; Goldstein, LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology. 2004;63:1230-1233.  Abstract
  • Bushnell, CD; Newby, LK; Goldstein, LB; Lin, F; Yaffe, K; Simon, JA. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004;62:968-970.  Abstract
  • Camilo, O; Goldstein, LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35:1769-1775.  Abstract
  • Goldstein, LB. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004;43:137-141.  Abstract
  • Goldstein, LB. Neuroprotective therapy for acute ischaemic stroke: down, but not out. Lancet. 2004;363:414-415.  Abstract
  • Goldstein, LB; Amarenco, P. Prevention and health services delivery. Stroke. 2004;35:401-403.  Abstract
  • Goldstein, LB; Amarenco, P; Bogousslavsky, J; Callahan, AS; Hennerici, MG; Welch, KM; Zivin, J; Sillesen, H. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovascular Diseases. 2004;18:1-2.  Abstract
  • Goldstein, LB; Samsa, GP; Matchar, DB; Horner, RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004;35:1941-1945.  Abstract
  • Popp, RJ; Smith, SC; Adams, RJ; Antman, EM; Kavey, RE; DeMaria, AN; Ohman, EM; Pitt, B; Willerson, JT; Bellande, BJ; Fonarow, GC; Nishimura, RA; Shah, PM; Hirshfeld, JW; Messer, JV; Peterson, ED; Prystowsky, EN; Anderson, JL; Cheitlin, MD; Goldstein, LB; Grant, AO; Beller, GA; Hines, EF; Livingston, DW; McEntree, CW; American College of Cardiology Foundation, ; American Heart Association. ACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004;110:2506-2549.  Abstract
  • Rothwell, PM; Goldstein, LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke. 2004;35:2425-2427.  Abstract
  • Abou-Donia, MB; Abdel-Rahman, A; Goldstein, LB; Dechkovskaia, AM; Shah, DU; Bullman, SL; Khan, WA. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Archives of Toxicology. 2003;77:452-458.  Abstract
  • Adams, HP; Adams, RJ; Brott, T; del Zoppo, GJ; Furlan, A; Goldstein, LB; Grubb, RL; Higashida, R; Kidwell, C; Kwiatkowski, TG; Marler, JR; Hademenos, GJ; Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.  Abstract
  • Anderson, DJ; Goldstein, LB; Wilkinson, WE; Corey, GR; Cabell, CH; Sanders, LL; Sexton, DJ. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003;61:1341-1346.  Abstract
  • Bushnell, C; Goldstein, LB. Screening for hypercoagulable syndromes following stroke. Current Atherosclerosis Reports. 2003;5:291-298.  Abstract
  • Camilo, O; Goldstein, LB. Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. Stroke. 2003;34:2945-2950.  Abstract
  • Goldstein, LB. Amphetamines and related drugs in motor recovery after stroke. Physical Medicine and Rehabilitation Clinics of North America. 2003;14:S125-x.  Abstract
  • Goldstein, LB. Editorial comment--Advertising strategies to increase the public knowledge of the warning signs of stroke. Stroke. 2003;34:1968-1969.  Abstract
  • Goldstein, LB. Editorial comment--Prenatal influences on stroke mortality in England and Wales. Stroke. 2003;34:1602-1603.  Abstract
  • Goldstein, LB. Extracranial carotid artery stenosis. Stroke. 2003;34:2767-2773.  Abstract
  • Goldstein, LB. Model of recovery of locomotor ability after sensorimotor cortex injury in rats. Institute for Laboratory Animal Research (ILAR) Journal. 2003;44:125-129.  Abstract
  • Goldstein, LB. Neuropharmacology of TBI-induced plasticity. Brain Injury. 2003;17:685-694.  Abstract
  • Goldstein, LB. Pharmacotherapy in stroke rehabilitation. Advances in Neurology. 2003;92:447-450.  Abstract
  • Goldstein, LB. Prevention and health services delivery. Stroke. 2003;34:367-369.  Abstract
  • Goldstein, LB; Matchar, DB; Hoff-Lindquist, J; Samsa, GP; Horner, RD. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology. 2003;61:792-796.  Abstract
  • Goldstein, LB; Matchar, DB; Hoff-Lindquist, J; Samsa, GP; Horner, RD. Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke. 2003;34:999-1004.  Abstract
  • Marler, JR; Goldstein, LB. Medicine. Stroke--tPA and the clinic. Science. 2003;301:1677.  Abstract
  • McGirt, MJ; Blessing, RP; Goldstein, LB. Transcranial Doppler monitoring and clinical decision-making after subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2003;12:88-92.  Abstract
  • Pearson, TA; Bazzarre, TL; Daniels, SR; Fair, JM; Fortmann, SP; Franklin, BA; Goldstein, LB; Hong, Y; Mensah, GA; Sallis, JF; Smith, S; Stone, NJ; Taubert, KA; American Heart Association Expert Panel on Population and Prevention Science. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003;107:645-651.  Abstract
  • Abou-Donia, MB; Dechkovskaia, AM; Goldstein, LB; Bullman, SL; Khan, WA. Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats. Toxicological Sciences. 2002;66:148-158.  Abstract
  • Abou-Donia, MB; Dechkovskaia, AM; Goldstein, LB; Shah, DU; Bullman, SL; Khan, WA. Uranyl acetate-induced sensorimotor deficit and increased nitric oxide generation in the central nervous system in rats. Pharmacology, Biochemistry and Behavior. 2002;72:881-890.  Abstract
  • Bushnell, CD; Goldstein, LB. Homocysteine testing in patients with acute ischemic stroke. Neurology. 2002;59:1541-1546.  Abstract
  • Bushnell, CD; Goldstein, LB. Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. Stroke. 2002;33:948-953.  Abstract
  • Coull, BM; Williams, LS; Goldstein, LB; Meschia, JF; Heitzman, D; Chaturvedi, S; Johnston, KC; Starkman, S; Morgenstern, LB; Wilterdink, JL; Levine, SR; Saver, JL; American Academy of Neurology, ; American Stroke Association. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology. 2002;59:13-22.  Abstract
  • Coull, BM; Williams, LS; Goldstein, LB; Meschia, JF; Heitzman, D; Chaturvedi, S; Johnston, KC; Starkman, S; Morgenstern, LB; Wilterdink, JL; Levine, SR; Saver, JL; Joint Stroke Guideline Development Committee of the American Academy of Neurology, ; American Stroke Association. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002;33:1934-1942.  Abstract
  • Goldstein, LB; Albers, GW. Patient safety in trials of therapy for acute ischemic stroke. JAMA: Journal of the American Medical Association. 2002;287:987.  Abstract
  • Goldstein, LB; Bullman, S. Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats. Neurorehabilitation and Neural Repair. 2002;16:321-325.  Abstract
  • Goldstein, LB; Lyden, P; Mathias, SD; Colman, SS; Pasta, DJ; Albers, G; Atkinson, R; Kelley, G; Ng, K; Rylander, A. Telephone assessment of functioning and well-being following stroke: is it feasible?. Journal of Stroke and Cerebrovascular Diseases. 2002;11:80-87.  Abstract
  • Johnston, DC; Eastwood, JD; Nguyen, T; Goldstein, LB. Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice. Stroke. 2002;33:2834-2838.  Abstract
  • Johnston, DC; Goldstein, LB. Utility of noninvasive studies in the evaluation of patients with carotid artery disease. Current Neurology and Neuroscience Reports. 2002;2:25-30.  Abstract
  • Pearson, TA; Blair, SN; Daniels, SR; Eckel, RH; Fair, JM; Fortmann, SP; Franklin, BA; Goldstein, LB; Greenland, P; Grundy, SM; Hong, Y; Miller, NH; Lauer, RM; Ockene, IS; Sacco, RL; Sallis, JF; Smith, SC; Stone, NJ; Taubert, KA. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.  Abstract
  • Abou-Donia, MB; Goldstein, LB; Dechovskaia, A; Bullman, S; Jones, KH; Herrick, EA; Abdel-Rahman, AA; Khan, WA. Effects of daily dermal application of DEET and epermethrin, alone and in combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in rats. Journal of Toxicology and Environmental Health Part A. 2001;62:523-541.  Abstract
  • Abou-Donia, MB; Goldstein, LB; Jones, KH; Abdel-Rahman, AA; Damodaran, TV; Dechkovskaia, AM; Bullman, SL; Amir, BE; Khan, WA. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicological Sciences. 2001;60:305-314.  Abstract
  • Albers, GW; Goldstein, LB; Hall, D; Lesko, LM; Aptiganel Acute Stroke Investigators. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA: Journal of the American Medical Association. 2001;286:2673-2682.  Abstract
  • Bushnell, C; Siddiqi, Z; Morgenlander, JC; Goldstein, LB. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. Neurology. 2001;56:624-627.  Abstract
  • Bushnell, CD; Datta, SK; Goldstein, LB. Cost implications of specialized coagulation testing for acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2001;10:279-283.  Abstract
  • Bushnell, CD; Johnston, DC; Goldstein, LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke. 2001;32:656-660.  Abstract
  • Bushnell, CD; Samsa, GP; Goldstein, LB. Hormone replacement therapy and ischemic stroke severity in women: a case-control study. Neurology. 2001;56:1304-1307.  Abstract
  • Bushnell, CD; Siddiqi, Z; Goldstein, LB. Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke. Neurology. 2001;57:1333-1335.  Abstract
  • Goldstein, LB. Medical therapy for acute ischemic stroke. Current Atherosclerosis Reports. 2001;3:299-306.  Abstract
  • Goldstein, LB; Adams, R; Becker, K; Furberg, CD; Gorelick, PB; Hademenos, G; Hill, M; Howard, G; Howard, VJ; Jacobs, B; Levine, SR; Mosca, L; Sacco, RL; Sherman, DG; Wolf, PA; del Zoppo, GJ. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2001;103:163-182.  Abstract
  • Goldstein, LB; Adams, R; Becker, K; Furberg, CD; Gorelick, PB; Hademenos, G; Hill, M; Howard, G; Howard, VJ; Jacobs, B; Levine, SR; Mosca, L; Sacco, RL; Sherman, DG; Wolf, PA; del Zoppo, GJ. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.  Abstract
  • Goldstein, LB; Edwards, MG; Wood, DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology. 2001;20:196-200.  Abstract
  • Goldstein, LB; Jones, MR; Matchar, DB; Edwards, LJ; Hoff, J; Chilukuri, V; Armstrong, SB; Horner, RD. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001;32:1091-1098.  Abstract
  • Johnston, DC; Chapman, KM; Goldstein, LB. Low rate of complications of cerebral angiography in routine clinical practice. Neurology. 2001;57:2012-2014.  Abstract
  • Johnston, DC; Goldstein, LB. Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography. Neurology. 2001;56:1009-1015.  Abstract
  • Smith Hammond, CA; Goldstein, LB; Zajac, DJ; Gray, L; Davenport, PW; Bolser, DC. Assessment of aspiration risk in stroke patients with quantification of voluntary cough. Neurology. 2001;56:502-506.  Abstract
  • Bushnell, CD; Goldstein, LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 2000;31:3067-3078.  Abstract
  • Goldstein, LB. Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology. 2000;39:852-859.  Abstract
  • Goldstein, LB. Novel risk factors for stroke: homocysteine, inflammation, and infection. Current Atherosclerosis Reports. 2000;2:110-114.  Abstract
  • Goldstein, LB. Rehabilitation and Recovery After Stroke. Current Treatment Options in Neurology. 2000;2:319-328.  Abstract
  • Goldstein, LB. Should antihypertensive therapies be given to patients with acute ischemic stroke?. Drug Safety. 2000;22:13-18.  Abstract
  • Goldstein, LB. The use of surface electromyography in objective measurement of the muscle function in facial pain/temporomandibular dysfunction patients. The Functional orthodontist. 2000;17:26-29.  Abstract
  • Goldstein, LB; Bian, J; Samsa, GP; Bonito, AJ; Lux, LJ; Matchar, DB. New transient ischemic attack and stroke: outpatient management by primary care physicians. Archives of Internal Medicine. 2000;160:2941-2946.  Abstract
  • Goldstein, LB; Hey, LA; Laney, R. North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. Stroke. 2000;31:66-70.  Abstract
  • Goldstein, LB; Howard, G. Stroke in patients with asymptomatic internal-carotid-artery stenosis. New England Journal of Medicine. 2000;343:1420.  Abstract
  • Goldstein, LB; Vitek, MP; Dawson, H; Bullman, S. Expression of the apolipoprotein E gene does not affect motor recovery after sensorimotor cortex injury in the mouse. Neuroscience. 2000;99:705-710.  Abstract
  • Samsa, GP; Matchar, DB; Goldstein, LB; Bonito, AJ; Lux, LJ; Witter, DM; Bian, J. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Archives of Internal Medicine. 2000;160:967-973.  Abstract
  • Goldstein, LB. Amphetamine-facilitated poststroke recovery. Stroke. 1999;30:696-698.  Abstract
  • Goldstein, LB. Carotid endarterectomy for stroke prevention in older people. Clinics in Geriatric Medicine. 1999;15:685-700.  Abstract
  • Goldstein, LB. Carotid endarterectomy. New England Journal of Medicine. 1999;340:1209.  Abstract
  • Goldstein, LB. Evidence-based medicine and stroke. Neuroepidemiology. 1999;18:120-124.  Abstract
  • Goldstein, LB. Pharmacological approach to functional reorganization: the role of norepinephrine. Revue Neurologique. 1999;155:731-736.  Abstract
  • Goldstein, LB; Brott, TG; Kothari, RU; Smith, WS. Clinical stroke trials: guarding against bias. Stroke. 1999;30:1165-1166.  Abstract
  • Goldstein, LB; Bullman, S. Age but not sex affects motor recovery after unilateral sensorimotor cortex suction-ablation in the rat. Restorative Neurology and Neuroscience. 1999;15:39-43.  Abstract
  • Goldstein, LB; Chu, CT; Gray, L; Hulette, CM. Angiographically defined primary angiitis of the CNS: is it really benign?. Neurology. 1999;52:1302.  Abstract
  • Goldstein, LB; Gradison, M. Stroke-related knowledge among patients with access to medical care in the stroke belt. Journal of Stroke and Cerebrovascular Diseases. 1999;8:349-352.  Abstract
  • Wolf, PA; Clagett, GP; Easton, JD; Goldstein, LB; Gorelick, PB; Kelly-Hayes, M; Sacco, RL; Whisnant, JP. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999;30:1991-1994.  Abstract
  • Chu, CT; Gray, L; Goldstein, LB; Hulette, CM. Diagnosis of intracranial vasculitis: a multi-disciplinary approach. Journal of Neuropathology and Experimental Neurology. 1998;57:30-38.  Abstract
  • Goldstein, LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29:1602-1604.  Abstract
  • Goldstein, LB. Potential effects of common drugs on stroke recovery. Archives of Neurology. 1998;55:454-456.  Abstract
  • Goldstein, LB; Cohen, SJ; Matchar, DB; Bonito, AJ; Samsa, GP. Physician-reported readiness to change stroke prevention practices. Journal of Stroke and Cerebrovascular Diseases. 1998;7:358-363.  Abstract
  • Goldstein, LB; Hey, LA; Laney, R. North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke. Stroke. 1998;29:2069-2072.  Abstract
  • Goldstein, LB; Samsa, GP; Matchar, DB; Oddone, EZ. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke. 1998;29:750-753.  Abstract
  • Whetten-Goldstein, K; Sloan, FA; Goldstein, LB; Kulas, ED. A comprehensive assessment of the cost of multiple sclerosis in the United States. Multiple Sclerosis. 1998;4:419-425.  Abstract
  • Duncan, PW; Samsa, GP; Weinberger, M; Goldstein, LB; Bonito, A; Witter, DM; Enarson, C; Matchar, D. Health status of individuals with mild stroke. Stroke. 1997;28:740-745.  Abstract
  • Goldstein, LB. Effects of bilateral and unilateral locus coeruleus lesions on beam-walking recovery after subsequent unilateral sensorimotor cortex suction-ablation in the rat. Restorative Neurology and Neuroscience. 1997;11:55-63.  Abstract
  • Goldstein, LB. Influence of common drugs and related factors on stroke outcome. Current Opinion in Neurology. 1997;10:52-57.  Abstract
  • Goldstein, LB; Bullman, S. Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury. Pharmacology, Biochemistry and Behavior. 1997;58:1151-1157.  Abstract
  • Goldstein, LB; Chilukuri, V. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. Stroke. 1997;28:1181-1184.  Abstract
  • Goldstein, LB; Farmer, A; Matchar, DB. Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. Stroke. 1997;28:746-751.  Abstract
  • Goldstein, LB; Last, FC; Salerno, VM. Prevalence of hyperactive digastric muscles during swallowing as measured by electromyography in patients with myofascial pain dysfunction syndrome. The Functional orthodontist. 1997;14:18-24.  Abstract
  • Goldstein, LB; Moore, WS; Robertson, JT; Chaturvedi, S. Complication rates for carotid endarterectomy. A call to action. Stroke. 1997;28:889-890.  Abstract
  • Goldstein, LB; Samsa, GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997;28:307-310.  Abstract
  • Matchar, DB; Oddone, EZ; McCrory, DC; Goldstein, LB; Landsman, PB; Samsa, G; Brook, RH; Kamberg, C; Hilborne, L; Leape, L; Horner, R. Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center Consortium. Health Services Research. 1997;32:325-342.  Abstract
  • Sacco, RL; Benjamin, EJ; Broderick, JP; Dyken, M; Easton, JD; Feinberg, WM; Goldstein, LB; Gorelick, PB; Howard, G; Kittner, SJ; Manolio, TA; Whisnant, JP; Wolf, PA. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke. 1997;28:1507-1517.  Abstract
  • Samsa, GP; Cohen, SJ; Goldstein, LB; Bonito, AJ; Duncan, PW; Enarson, C; DeFriese, GH; Horner, RD; Matchar, DB. Knowledge of risk among patients at increased risk for stroke. Stroke. 1997;28:916-921.  Abstract
  • Goldstein, LB. Sacral pseudoradiculopathy due to centrum semiovale stroke. Journal of Stroke and Cerebrovascular Diseases. 1996;6:41-44.  Abstract
  • Goldstein, LB; Bonito, AJ; Matchar, DB; Duncan, PW; Samsa, GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. Stroke. 1996;27:801-806.  Abstract
  • Goldstein, LB; Bonito, AJ; Matchar, DB; Duncan, PW; Samsa, GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis. Stroke. 1996;27:1473-1478.  Abstract
  • Alberts, MJ; Goldstein, LB; Smith, T. Guidelines on the use of thrombolytic agents in stroke. JAMA: Journal of the American Medical Association. 1995;274:218.  Abstract
  • Goldstein, LB. Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology. 1995;45:865-871.  Abstract
  • Goldstein, LB. Prescribing of potentially harmful drugs to patients admitted to hospital after head injury. Journal of Neurology, Neurosurgery and Psychiatry. 1995;58:753-755.  Abstract
  • Goldstein, LB. Right vs. left sensorimotor cortex suction-ablation in the rat: no difference in beam-walking recovery. Brain Research. 1995;674:167-170.  Abstract
  • Goldstein, LB; Bonito, AJ; Matchar, DB; Duncan, PW; DeFriese, GH; Oddone, EZ; Paul, JE; Akin, DR; Samsa, GP. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. Stroke. 1995;26:1607-1615.  Abstract
  • Goldstein, LB; Gray, L; Hulette, CM. Stroke due to recurrent ipsilateral carotid artery dissection in a young adult. Stroke. 1995;26:480-483.  Abstract
  • Goldstein, LB; Hasselblad, V; Matchar, DB; McCrory, DC. Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis. Neurology. 1995;45:1965-1970.  Abstract
  • Grotta, J; Clark, W; Coull, B; Pettigrew, LC; Mackay, B; Goldstein, LB; Meissner, I; Murphy, D; LaRue, L. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke. 1995;26:602-605.  Abstract
  • Duncan, PW; Goldstein, LB; Horner, RD; Landsman, PB; Samsa, GP; Matchar, DB. Similar motor recovery of upper and lower extremities after stroke. Stroke. 1994;25:1181-1188.  Abstract
  • Goldstein, LB. Clinical preventive practice. Health Reports. 1994;6:139-141.  Abstract
  • Goldstein, LB. Sample size calculations for clinical trials using the NIH Stroke Scale. Stroke. 1994;25:1700-1701.  Abstract
  • Goldstein, LB; Matchar, DB. The Stroke P.O.R.T.: secondary and tertiary prevention of ischemic stroke. Stroke Prevention Patient Outcomes Research Team. Health Reports. 1994;6:154-159.  Abstract
  • Goldstein, LB; Matchar, DB. The rational clinical examination. Clinical assessment of stroke. JAMA: Journal of the American Medical Association. 1994;271:1114-1120.  Abstract
  • Goldstein, LB; McCrory, DC; Landsman, PB; Samsa, GP; Ancukiewicz, M; Oddone, EZ; Matchar, DB. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994;25:1116-1121.  Abstract
  • Goldstein, LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. Journal of Neural Transplantation and Plasticity. 1993;4:175-192.  Abstract
  • Goldstein, LB. Rapid reliable measurement of lesion parameters for studies of motor recovery after sensorimotor cortex injury in the rat. Journal of Neuroscience Methods. 1993;48:35-42.  Abstract
  • Goldstein, LB; Macmillan, V. Acute unilateral sensorimotor cortex injury in the rat blocks d-amphetamine induced norepinephrine release in cerebellum. Restorative Neurology and Neuroscience. 1993;5:371-376.  Abstract
  • McCrory, DC; Goldstein, LB; Samsa, GP; Oddone, EZ; Landsman, PB; Moore, WS; Matchar, DB. Predicting complications of carotid endarterectomy. Stroke. 1993;24:1285-1291.  Abstract
  • Duncan, PW; Goldstein, LB; Matchar, D; Divine, GW; Feussner, J. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992;23:1084-1089.  Abstract
  • Goldstein, LB; Coviello, A. Post-lesion administration of the NMDA receptor antagonist MK-801 does not impair motor recovery after unilateral sensorimotor cortex injury in the rat. Brain Research. 1992;580:129-136.  Abstract
  • Goldstein, LB; Perry, A. Early recurrent ischemic stroke. A case-control study. Stroke. 1992;23:1010-1013.  Abstract
  • Goldstein, LB; Coviello, A; Miller, GD; Davis, JN. Norepinephrine depletion impairs motor recovery following sensorimotor cortex injury in the rat. Restorative Neurology and Neuroscience. 1991;3:41-47.  Abstract
  • Morgenlander, JC; Goldstein, LB. Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. Stroke. 1991;22:94-98.  Abstract
  • Goldstein, LB. Pharmacology of recovery after stroke. Stroke. 1990;21:III139-III142.  Abstract
  • Goldstein, LB; Davis, JN. Beam-walking in rats: studies towards developing an animal model of functional recovery after brain injury. Journal of Neuroscience Methods. 1990;31:101-107.  Abstract
  • Goldstein, LB; Davis, JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Research. 1990;508:305-309.  Abstract
  • Goldstein, LB; Davis, JN. Influence of lesion size and location on amphetamine-facilitated recovery of beam-walking in rats. Behavioral Neuroscience. 1990;104:320-327.  Abstract
  • Goldstein, LB; Davis, JN. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restorative Neurology and Neuroscience. 1990;1:311-314.  Abstract
  • Goldstein, LB; Davis, JN. Restorative neurology. Drugs and recovery following stroke. Stroke. 1990;21:1636-1640.  Abstract
  • Massey, EW; Biller, J; Davis, JN; Adams, HP; Marler, JR; Goldstein, LB; Alberts, M; Bruno, A. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke. 1990;21:1289-1292.  Abstract
  • Biller, J; Massey, EW; Marler, JR; Adams, HP; Davis, JN; Bruno, A; Henriksen, RA; Linhardt, RJ; Goldstein, LB; Alberts, M. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Neurology. 1989;39:262-265.  Abstract
  • Goldstein, LB; Bertels, C; Davis, JN. Interrater reliability of the NIH stroke scale. Archives of Neurology. 1989;46:660-662.  Abstract
  • Goldstein, LB; Davis, JN. Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. Neurology. 1988;38:1806-1809.  Abstract
  • Epstein, HT; Goldstein, LB. Construction of low-variability litters of preweaning mice. Developmental Psychobiology. 1977;10:575-577.  Abstract
end fo content area